Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
Disease Category: Blood Clots

Trial Information

Extended anti-coagulation trial following a blood clot.

UVa Health System, Department of Medicine Division of Hematology and Oncology seeks people over age 18 who have experienced a blood clot (also known as a deep vein thrombosis or pulmonary embolism) in the past 12 months and are currently taking blood thinner medications (anticoagulants) for a for research study.

This purpose of this study is to determine the risks and benefits of continued anticoagulation using the investigational drug, apixiban, following standard 6-12 months of anti-coagulation for the treatment of a DVT or PE.

The study involves taking an experimental medicine/placebo and 7-8 out-patient clinic visits and monthly phone contacts over the course of a year. The visits may include: blood draws, ECGs, physical exams, urine samples and pregnancy tests when applicable. Each visit is expected to last about 1 hour.

Study-related exams, tests and experimental medication provided free of charge.
Compensation for each completed study visit is $50. Total possible compensation for this study is $400.

Contact Information:
For more information please contact the Surgical Therapeutic Advancement Center at:
Phone 434.243.0315
Email: uvastac@virginia.edu
IRB-HSR # 13883

Principal Investigator: B. Gail Macik, MD



www.healthsystem.virginia.edu/clinical_trials

Winsor Simmons Egolf RN
University of Virginia
School of Medicine
Hematology/Oncology, Internal Medicine
Charlottesville, VA 22908
Phone: 434-243-0315
Fax: 434-243-0318
EMail: wds5j@virginia.edu

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.